Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 401 to 425 of 2387

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Risankizumab for treating active psoriatic arthritis after inadequate response to DMARDsTA803
Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglyceridesTA805
Belimumab for treating lupus nephritis (terminated appraisal)TA806
Roxadustat for treating symptomatic anaemia in chronic kidney diseaseTA807
ProciseDx point-of-care platform for inflammatory bowel diseaseMIB302
Fenfluramine for treating seizures associated with Dravet syndromeTA808
Social, emotional and mental wellbeing in primary and secondary educationNG223
Setmelanotide for treating obesity caused by LEPR or POMC deficiencyHST21
Lenus COPD Support Service for remotely managing chronic obstructive pulmonary diseaseMIB300
Cyanoacrylate glue for hernia mesh fixationMIB301
MiraQ for assessing graft flow during coronary artery bypass graft surgeryMTG8
RespiraSense for continuously monitoring respiratory rateMIB299
Teduglutide for treating short bowel syndromeTA804
Faricimab for treating diabetic macular oedemaTA799
Faricimab for treating wet age-related macular degenerationTA800
Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancerTA801
Cemiplimab for treating advanced cutaneous squamous cell carcinomaTA802
Vertebral body tethering for idiopathic scoliosis in children and young peopleIPG728
Nerve graft for corneal denervationIPG729
Depression in adults: treatment and managementNG222
Type 2 diabetes in adults: managementNG28
Durvalumab for maintenance treatment of unresectable non-small-cell lung cancer after platinum-based chemoradiationTA798
Multiple sclerosis in adults: managementNG220
Venetoclax for treating chronic lymphocytic leukaemiaTA796
Enfortumab vedotin for previously treated locally advanced or metastatic urothelial cancer (terminated appraisal)TA797

Results per page

  1. 10
  2. 25
  3. 50
  4. All